LOX and glioblastoma: The results indicated that every member of the LOX family demonstrated an association with specific immunosuppressive agents in GBM (Figures 5A-E) and LGG (Figures 5F-J), thereby presenting evidence for the potential application of the LOX family in immunotherapy.